MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

AngioDynamics Inc

Suletud

SektorTervishoid

9.65 2.55

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

9.04

Max

9.67

Põhinäitajad

By Trading Economics

Sissetulek

2.7M

-11M

Müük

1.9M

73M

Aktsiakasum

-0.04

Kasumimarginaal

-14.741

Töötajad

748

EBITDA

3.8M

1.8M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+63.26% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

2. apr 2025

Turustatistika

By TradingEconomics

Turukapital

107M

384M

Eelmine avamishind

7.1

Eelmine sulgemishind

9.65

Uudiste sentiment

By Acuity

31%

69%

86 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

AngioDynamics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. dets 2024, 15:23 UTC

Suurimad hinnamuutused turgudel

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

9. dets 2024, 15:20 UTC

Suurimad hinnamuutused turgudel

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

4. apr 2024, 14:56 UTC

Tulu
Suurimad hinnamuutused turgudel

AngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 System

Võrdlus sarnastega

Hinnamuutus

AngioDynamics Inc Prognoos

Hinnasiht

By TipRanks

63.26% tõus

12 kuu keskmine prognoos

Keskmine 15.33 USD  63.26%

Kõrge 16 USD

Madal 15 USD

Põhineb 3 Wall Streeti analüütiku instrumendi AngioDynamics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

3

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

9.35 / 9.87Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Weak Bearish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

86 / 386 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.